Northern Trust’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Sell |
675,459
-14,716
| -2% | -$53K | ﹤0.01% | 2873 |
|
|
2025
Q1 | $2.06M | Sell |
690,175
-14,734
| -2% | -$44.1K | ﹤0.01% | 2911 |
|
|
2024
Q4 | $2.36M | Buy |
704,909
+17,471
| +3% | +$58.5K | ﹤0.01% | 2930 |
|
|
2024
Q3 | $2.3M | Buy |
687,438
+26,154
| +4% | +$87.6K | ﹤0.01% | 2918 |
|
|
2024
Q2 | $2.19M | Sell |
661,284
-25,985
| -4% | -$86K | ﹤0.01% | 2859 |
|
|
2024
Q1 | $2.78M | Sell |
687,269
-24,244
| -3% | -$97.9K | ﹤0.01% | 2794 |
|
|
2023
Q4 | $2.17M | Buy |
711,513
+45,361
| +7% | +$138K | ﹤0.01% | 2958 |
|
|
2023
Q3 | $2M | Buy |
666,152
+19,409
| +3% | +$58.2K | ﹤0.01% | 2940 |
|
|
2023
Q2 | $2.42M | Sell |
646,743
-58,301
| -8% | -$218K | ﹤0.01% | 2903 |
|
|
2023
Q1 | $2.36M | Sell |
705,044
-5,894
| -0.8% | -$19.7K | ﹤0.01% | 2866 |
|
|
2022
Q4 | $3.42M | Sell |
710,938
-14,288
| -2% | -$68.7K | ﹤0.01% | 2700 |
|
|
2022
Q3 | $4.13M | Buy |
725,226
+32,100
| +5% | +$183K | ﹤0.01% | 2614 |
|
|
2022
Q2 | $4.92M | Buy |
693,126
+133,106
| +24% | +$945K | ﹤0.01% | 2520 |
|
|
2022
Q1 | $4.04M | Sell |
560,020
-15,248
| -3% | -$110K | ﹤0.01% | 2712 |
|
|
2021
Q4 | $5.14M | Sell |
575,268
-16,093
| -3% | -$144K | ﹤0.01% | 2665 |
|
|
2021
Q3 | $20.7M | Buy |
591,361
+70,939
| +14% | +$2.49M | ﹤0.01% | 1782 |
|
|
2021
Q2 | $11.2M | Buy |
520,422
+353,262
| +211% | +$7.59M | ﹤0.01% | 2293 |
|
|
2021
Q1 | $10.3M | Sell |
167,160
-9,745
| -6% | -$602K | ﹤0.01% | 2269 |
|
|
2020
Q4 | $7.39M | Buy |
+176,905
| New | +$7.39M | ﹤0.01% | 2445 |
|